Market Closed -
Bombay S.E.
06:24:06 2024-04-30 am EDT
|
5-day change
|
1st Jan Change
|
46.41
INR
|
-4.11%
|
|
+5.79%
|
-7.53%
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
975.7
|
1,588
|
769.4
|
2,779
|
20,890
|
19,613
|
Enterprise Value (EV)
1 |
730.1
|
1,188
|
962
|
2,728
|
21,251
|
20,750
|
P/E ratio
|
-20.2
x
|
2.84
x
|
8.75
x
|
30.1
x
|
34.5
x
|
14.3
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.29
x
|
0.42
x
|
0.26
x
|
1.23
x
|
4.6
x
|
2.77
x
|
EV / Revenue
|
0.22
x
|
0.32
x
|
0.33
x
|
1.21
x
|
4.68
x
|
2.93
x
|
EV / EBITDA
|
2.39
x
|
1.59
x
|
6.51
x
|
6.87
x
|
21.2
x
|
9.6
x
|
EV / FCF
|
1.79
x
|
-26.2
x
|
-1.23
x
|
107
x
|
-15.1
x
|
-39
x
|
FCF Yield
|
55.8%
|
-3.81%
|
-81.1%
|
0.93%
|
-6.62%
|
-2.57%
|
Price to Book
|
2.68
x
|
2.43
x
|
1.09
x
|
2.88
x
|
7.56
x
|
4.75
x
|
Nbr of stocks (in thousands)
|
135,704
|
135,704
|
135,704
|
155,704
|
242,343
|
242,343
|
Reference price
2 |
7.190
|
11.70
|
5.670
|
17.85
|
86.20
|
80.93
|
Announcement Date
|
8/14/18
|
8/23/19
|
9/7/20
|
9/8/21
|
8/24/22
|
9/6/23
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,375
|
3,757
|
2,904
|
2,263
|
4,541
|
7,074
|
EBITDA
1 |
305.7
|
746.9
|
147.8
|
397
|
1,001
|
2,162
|
EBIT
1 |
249.3
|
635.6
|
49.58
|
242
|
840.1
|
1,938
|
Operating Margin
|
7.39%
|
16.92%
|
1.71%
|
10.69%
|
18.5%
|
27.4%
|
Earnings before Tax (EBT)
1 |
-48.22
|
587.5
|
181.7
|
200.7
|
755.4
|
1,899
|
Net income
1 |
-48.22
|
558.6
|
88.05
|
82.37
|
567.2
|
1,374
|
Net margin
|
-1.43%
|
14.87%
|
3.03%
|
3.64%
|
12.49%
|
19.42%
|
EPS
2 |
-0.3560
|
4.116
|
0.6480
|
0.5940
|
2.500
|
5.670
|
Free Cash Flow
1 |
407.2
|
-45.27
|
-780.3
|
25.5
|
-1,408
|
-532.3
|
FCF margin
|
12.07%
|
-1.2%
|
-26.87%
|
1.13%
|
-31%
|
-7.52%
|
FCF Conversion (EBITDA)
|
133.2%
|
-
|
-
|
6.42%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
30.96%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/14/18
|
8/23/19
|
9/7/20
|
9/8/21
|
8/24/22
|
9/6/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
193
|
-
|
361
|
1,137
|
Net Cash position
1 |
246
|
400
|
-
|
51.4
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.303
x
|
-
|
0.3604
x
|
0.5261
x
|
Free Cash Flow
1 |
407
|
-45.3
|
-780
|
25.5
|
-1,408
|
-532
|
ROE (net income / shareholders' equity)
|
-12.8%
|
110%
|
13%
|
9.86%
|
30.4%
|
39.9%
|
ROA (Net income/ Total Assets)
|
7.77%
|
18.2%
|
1.36%
|
6.39%
|
14.5%
|
20%
|
Assets
1 |
-620.3
|
3,074
|
6,451
|
1,289
|
3,911
|
6,862
|
Book Value Per Share
2 |
2.690
|
4.820
|
5.190
|
6.210
|
11.40
|
17.00
|
Cash Flow per Share
2 |
3.970
|
2.950
|
0.6500
|
0.4900
|
0.9900
|
0.8900
|
Capex
1 |
49.2
|
353
|
925
|
249
|
1,569
|
1,823
|
Capex / Sales
|
1.46%
|
9.4%
|
31.85%
|
10.98%
|
34.55%
|
25.77%
|
Announcement Date
|
8/14/18
|
8/23/19
|
9/7/20
|
9/8/21
|
8/24/22
|
9/6/23
|
|
1st Jan change
|
Capi.
|
---|
| -7.53% | 141M | | +4.87% | 103B | | +2.40% | 68.41B | | +42.86% | 39.97B | | +16.96% | 38.97B | | +6.96% | 33.12B | | +7.89% | 19.41B | | +12.12% | 16.73B | | +12.08% | 15.34B | | +17.69% | 15.07B |
Other Commodity Chemicals
|